All posts by Anthony King

Anthony King is a freelance science writer based in Dublin, Ireland. He has contributed news and feature articles to the Irish Times, and science magazines such as New Scientist, Cosmos Magazine, Discover, Chemistry & Industry and Chemistry World, as well as journals such as Cell, Nature and Science. He writes primarily about the biological and chemical sciences, but also has an interest in policy.

Citizen journalism: A phenomenon that is here to stay

As the catastrophic fire blazed in Grenfell Tower, London in June 2017, everyone knew they would find photos or videos online, posted by citizens, on the scene before the professional journalists. Citizen journalists are now a common presence in the event of disasters, natural and man-made, but they represent a remarkably new phenomenon. This and other new media topics are the subject of discussions in Copenhagen at the 4th European Conference for Science Journalists. Read more [...]
This post was viewed 111 times.

Artist Olafur Eliasson on art, science and environmental consciousness

I believe art can offer people direct experiences of phenomena … I feel that this is an important step towards motivating people not just to know something but also to respond to it, to feel the urgency of it and to take action. Read more [...]
This post was viewed 2,304 times.

The logic behind the Stop Vivisection campaign

An anti-vivisection citizen initiative has gathered over 1.2 milion signatures. Despite lengthy debates related to the Directive on the use of animal in research, anti-vivisection campaigner still oppose any use of animals in research. The initiators of the petition, who include some scientists, argue that animal studies cannot predict how humans respond to drugs or chemicals. The move has triggered a strong response from the science community. Yet, some anticipate there could be a better way of dealing with such issues involving greater citizen engagement. Read more [...]
This post was viewed 76 times.

Blowback – Spy scandal threatens European research

The Snowden fallout it far from being over. One of its consequences is the European Parliament’s text for upcoming Data Protection legislation. The draft proposal has resulted in some of the largest, most prestigious, non-commercial research organisations in Europe being up in arms. They warn that the EU is set to strangle health-saving research. In this feature article, EuroScientist investigates what could be the possible consequences, should the legislation does not make suitable exception to allow research of potential future societal value and privacy at all costs becomes the new rule. Read more [...]
This post was viewed 44 times.

When negative data fails patients by publication omission

Half of all clinical trials never see the light of day. There are regulations in Europe and the US; they are often ignored. But public pressure has begun to push the pharmaceutical industries to make trial data available. However, in a world where industry, clinicians and medical publishers are complicit in not having clinical trials published in full, it may be necessary to give ownership of clinical data back to patients to gain greater transparency and accountability. Read more [...]
This post was viewed 94 times.